In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 80, Issue 5, Pages 1122-1130
Publisher
Wiley
Online
2015-04-24
DOI
10.1111/bcp.12665
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
- (2014) J. Hicks et al. CURRENT DRUG METABOLISM
- Functional Characterization of Wild-type and 49 CYP2D6 Allelic Variants for N-Desmethyltamoxifen 4-Hydroxylation Activity
- (2014) Yuka Muroi et al. Drug Metabolism and Pharmacokinetics
- Functional characterization of CYP2D6 enhancer polymorphisms
- (2014) Danxin Wang et al. HUMAN MOLECULAR GENETICS
- Resolution of a clinical AmpliChip CYP450 Test™ no call: discovery and characterization of novelCYP2D6*1haplotypes
- (2014) Andrea Gaedigk et al. PHARMACOGENOMICS
- Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
- (2014) P Saladores et al. PHARMACOGENOMICS JOURNAL
- CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
- (2013) Wendy A. Teft et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
- (2013) J K Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity
- (2013) Danxin Wang et al. HUMAN MOLECULAR GENETICS
- Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies
- (2013) Kazuma Kiyotani et al. JOURNAL OF HUMAN GENETICS
- PharmGKB summary
- (2013) Daniel J. Klein et al. Pharmacogenetics and Genomics
- CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8
- (2012) M. P. Goetz et al. CLINICAL CANCER RESEARCH
- CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
- (2012) Meredith M. Regan et al. JNCI-Journal of the National Cancer Institute
- Tamoxifen and CYP2D6: A Contradiction of Data
- (2012) D. L. Hertz et al. ONCOLOGIST
- Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
- (2011) T E Mürdter et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
- (2011) L Madlensky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
- (2011) William J. Irvin et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
- (2010) K Abduljalil et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
- (2010) Silvana Borges et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started